NEW YORK (GenomeWeb) – Next-generation sequencing-based diagnostics firm Guardant Health today announced it raised $30 million in a Series B financing.

Khosla Ventures led the round and was joined by existing investor Sequoia Capital and new investor Pejman Mar Ventures.

The financing "will allow Guardant Health to accelerate the expansion of its commercial operations to support growing demand and ensure a distinctively high level of service for our physicians and patients," Guardant CEO and Co-Founder Helmy Eltoukhy said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.